Immunogenicity 11390

summary
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
MAGEB18
Transcript ID
uc004dbq.2
HLA INFO
B*40:01
TCR INFO

No TCR info found!

T cell Tumor cell B*40:01
sequence
Full length protein sequence (343 aa)
MPRGQ
1
KSKLR
6
AREKR
11
HQARC
16
ENQDL
21
GATQA
26
TVAEG
31
ESPSS
36
AYLLF
41
GDRPQ
46
NLPAA
51
ETPSI
56
PEALQ
61
GAPST
66
TNAIA
71
PVSCS
76
SNEGA
81
SSQDE
86
KSLGS
91
SREAE
96
GWKED
101
PLNKK
106
VVSLV
111
HFLLQ
116
KYETK
121
EPITK
126
GDMIK
131
FVIRK
136
DKCHF
141
NEILK
146
RASEH
151
MELAL
156
GVDLK
161
EVDPI
166
RHYYA
171
FFSKL
176
DLTYD
181
ETTSD
186
EEKIP
191
KTGLL
196
MIALG
201
VIFLN
206
GNRAP
211
EEAVW
216
EIMNM
221
MGVYA
226
DRKHF
231
LYGDP
236
RKVMT
241
KDLVQ
246
LKYLE
251
YQQVP
256
NSDPP
261
RYEFL
266
WGPRA
271
HAETS
276
KMKVL
281
EFVAK
286
IHDTV
291
PSAFP
296
SCYEE
301
ALRDE
306
EQRTQ
311
ARAAA
316
RAHTA
321
AMANA
326
RSRTT
331
SSSFS
336
HAK
341
Mutation Information
DNA mutation:
None
Peptide Range:
24 ~ 48
Mut AA position:
36 (13 in Wild Type peptide)
Alignment
Wild Type:
"DLGATQATVAEGESPSSAYLLFGDR
||||||||||||.||||||||||||
Mutant:
DLGATQATVAEGQSPSSAYLLFGDR"
reference
clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay